113 related articles for article (PubMed ID: 38820773)
21. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
22. ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer.
Li M; Zhang N; Shan W; Guan B
Ann Clin Lab Sci; 2022 Jan; 52(1):117-125. PubMed ID: 35181625
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor RUNX3 promotes CD8
Song Q; Shang J; Zhang C; Chen J; Zhang L; Wu X
J Cell Biochem; 2020 Jun; 121(5-6):3208-3220. PubMed ID: 31898342
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy.
Liu P; Lin C; Liu Z; Zhu C; Lin Z; Xu D; Chen J; Huang Q; Li CY; Hou L; Pan JA; Liu X
Cell Mol Life Sci; 2022 Jun; 79(7):352. PubMed ID: 35676564
[TBL] [Abstract][Full Text] [Related]
25. CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.
Li Y; Han S; Wu B; Zhong C; Shi Y; Lv C; Fu L; Zhang Y; Lang Q; Liang Z; Yu Y; Tian Y
Front Immunol; 2022; 13():951247. PubMed ID: 35935945
[TBL] [Abstract][Full Text] [Related]
26. CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers.
Gu Q; Zhou S; Chen C; Wang Z; Xu W; Zhang J; Wei S; Yang J; Chen H
Aging (Albany NY); 2023 Nov; 15(21):12369-12387. PubMed ID: 37944262
[TBL] [Abstract][Full Text] [Related]
27. COPS6 promotes tumor progression and reduces CD8
Du WQ; Zhu ZM; Jiang X; Kang MJ; Pei DS
Acta Pharmacol Sin; 2023 Sep; 44(9):1890-1905. PubMed ID: 37095198
[TBL] [Abstract][Full Text] [Related]
28. ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p.
Ke SB; Qiu H; Chen JM; Shi W; Han C; Gong Y; Chen YS
Pathol Res Pract; 2020 Mar; 216(3):152761. PubMed ID: 31899049
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Qin Y; Vasilatos SN; Chen L; Wu H; Cao Z; Fu Y; Huang M; Vlad AM; Lu B; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2019 Jan; 38(3):390-405. PubMed ID: 30111819
[TBL] [Abstract][Full Text] [Related]
30. Multi-omics Analyses Reveal Function of Apolipoprotein E in Alternative Splicing and Tumor Immune Microenvironment in Kidney Renal Clear Cell Carcinoma via Pan-cancer Analysis.
Leng X; Liu J; Jin A; Zheng H; Wu J; Zhong L; Li Q; Li D
Cell Biochem Biophys; 2024 Mar; 82(1):1-13. PubMed ID: 38182861
[TBL] [Abstract][Full Text] [Related]
31. Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker.
Cui L; Zhu L; Chen J; Li C; Yu Y; Xu S
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895310
[TBL] [Abstract][Full Text] [Related]
32. The association of PD-L1 expression and CD8-positive T cell infiltration rate with the pathological complete response after neoadjuvant treatment in HER2-positive breast cancer.
Çetin K; Kökten Ş; Sarıkamış B; Yıldırım S; Gökçe ON; Barışık NÖ; Kılıç Ü
Breast Cancer Res Treat; 2024 May; 205(1):17-27. PubMed ID: 38273215
[TBL] [Abstract][Full Text] [Related]
33. The Macrophage migration inhibitory factor is a vital player in Pan-Cancer by functioning as a M0 Macrophage biomarker.
Pu Y; Yang G; Zhou Y; Pan X; Guo T; Chai X
Int Immunopharmacol; 2024 Jun; 134():112198. PubMed ID: 38733827
[TBL] [Abstract][Full Text] [Related]
34. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
36. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive pan-cancer analysis of CDH5 in immunological response.
Li Y; Wu Q; Lv J; Gu J
Front Immunol; 2023; 14():1239875. PubMed ID: 37809080
[TBL] [Abstract][Full Text] [Related]
38. TGF-β1 precursor and CD8 are potential prognostic and predictive markers in operated breast cancer.
Yu HM; Yang JL; Jiao SC; Wang JD; Li Y
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):51-58. PubMed ID: 24496679
[TBL] [Abstract][Full Text] [Related]
39. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8
Fang W; Zhou T; Shi H; Yao M; Zhang D; Qian H; Zeng Q; Wang Y; Jin F; Chai C; Chen T
J Exp Clin Cancer Res; 2021 Jan; 40(1):4. PubMed ID: 33390170
[TBL] [Abstract][Full Text] [Related]
40. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
Liang H; Zhou G; Lv L; Lu J; Peng J
Breast Cancer; 2021 Mar; 28(2):379-386. PubMed ID: 33067762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
